Analyst Viewpoint
Rise in prevalence of blood-related chronic diseases is fueling the blood transfusion diagnostics market size. Sickle cell anemia and leukemia require blood and blood component transfusion and diagnostics products for long-term patient care. Analyzers, centrifuges, and kits & reagents are gaining traction for blood screening, grouping, and testing.
Prominent players operating in the global blood transfusion diagnostics industry are investing in the R&D of new products to expand their product portfolio. They are also adopting automation to optimize blood collection processes. Introduction of advanced transfusion techniques is likely to offer lucrative blood transfusion diagnostics market opportunities to vendors.
Blood transfusion is a medical procedure in which blood is intravenously transferred between a donor and a patient. The procedure is minimally intrusive and usually occurs without any complication in 2-4 hours. Blood transfusion diagnostics are products applied to conduct tests before the transfusion of blood. These products include instruments such as analyzers, centrifuges, and kits & reagents for blood grouping and screening activities. Blood screening reagents and kits are used in the red blood cell determination of the ABO blood group. Blood donor screening is conducted before transfusion for certain additional proteins (antibodies) that may cause adverse reactions in a person receiving the transfusion.
People aged 65 years and over often require blood transfusion, especially those suffering from anemia. Children in developing countries are usually susceptible to malaria, anemia, and trauma-related injuries and may require blood transfusion for effective treatment.
Chronic diseases such as aplastic anemia, sickle cell anemia, hemophilia, and leukemia require blood or blood component transfusion. A significant increase in the global geriatric population, sedentary lifestyles, and surge in pollution are some of the major factors propelling the prevalence of blood-related chronic diseases.
According to the World Health Organization, over 118.5 million units of blood is donated and collected annually. However, there is a growing need for transfusions due to a rise in the prevalence of blood-related diseases worldwide. This, in turn, is projected to spur the blood transfusion diagnostics market growth in the near future.
According to a report by the National Sickle Cell Anaemia Elimination Mission, around 140,000 people in India suffer from sickle cell anemia. As per the reports by the Canadian Hemophilia Society, published in February 2022, around 3,100 people in Canada suffered from Hemophilia A and B. Hence, increase in prevalence of blood-related chronic diseases is driving the blood transfusion diagnostics market revenue.
Government and private organizations are focused on boosting awareness regarding blood donation. In October 2022, National Health Service (NHS) Blood and Transplant started a blood donation campaign to combat sickle cell anemia and improve the number of blood donors for the disease. Private employers are also encouraging their workers to donate blood. These initiatives are propelling the blood transfusion diagnostics market progress. Automation is gaining traction in blood collection facilities. It helps reduce the time required for blood tests, thereby accelerating the blood transfusion process. Governments in various countries are implementing stringent blood testing regulations. This is prompting vendors to develop standard blood transfusion diagnostic products and solutions that adhere to these regulations.
According to the latest blood transfusion diagnostics market analysis, North America held largest share in 2022. Presence of several active blood donors and increase in number of blood transfusions are fueling the market dynamics of the region. The U.S. and Canada are major markets for blood transfusion diagnostics due to the implementation of stringent blood test safety policies.
As per the latest blood transfusion diagnostics market forecast, the industry in Asia Pacific is expected to grow at a steady pace during the forecast period. Rise in geriatric population and growth in cases of blood-related disorders are driving the market landscape in the region. China and India are major markets for blood transfusion diagnostics owing to the presence of a large patient pool requiring blood transfusions and growth in awareness regarding infectious diseases.
According to recent blood transfusion diagnostics market trends, prominent manufacturers are investing heavily in the development of advanced blood typing diagnostics. Close collaborations within the industry along with mergers and acquisitions are seen as key strategies to build a better product portfolio and maintain a strong stand in the sector. In March 2021, Bio-Rad Laboratories, Inc. entered a global partnership with F. Hoffmann-La Roche AG to offer customers a range of bar-coded, load-and-go quality control tubes that enhance workflow productivity and efficiency.
BAG Health Care GmbH, Abbott, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, DiaSorin S.p.A., Grifols, S.A., Werfen, Hologic, Inc., Ortho Clinical Diagnostics, and Alive Dx are key companies operating in this market.
These companies have been profiled in the blood transfusion diagnostics market report based on various parameters such as company overview, business strategies, product portfolio, financial overview, and business segments.
Attribute | Detail |
---|---|
Market Value in 2022 (Base Year) | US$ 4.3 Bn |
Market Forecast Value in 2031 | US$ 6.6 Bn |
Growth Rate (CAGR) | 5.0% |
Forecast Period | 2023-2031 |
Historical Data Available for | 2021 |
Quantitative Units | US$ Bn for Value |
Market Analysis | Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis. |
Competition Landscape |
|
Format | Electronic (PDF) + Excel |
Regions Covered |
|
Countries Covered |
|
Market Segmentation |
|
Companies Profiled |
|
Customization Scope | Available upon Request |
Pricing | Available upon Request |
It was valued at US$ 4.3 Bn in 2022
It is projected to grow at a CAGR of 5.0% from 2023 to 2031
Rise in prevalence of blood-related diseases and high demand for blood donations
The kits & reagents product type segment held the largest share in 2022
North America dominated the global landscape in 2022
BAG Health Care GmbH, Abbott, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, DiaSorin S.p.A., Grifols, S.A., Werfen, Hologic, Inc., Ortho Clinical Diagnostics, and Alive Dx
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Blood Transfusion Diagnostics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Blood Transfusion Diagnostics Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Blood Transfusion Diagnostics Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Instruments
6.3.2. Kits & Reagents
6.4. Market Attractiveness Analysis, by Product Type
7. Global Blood Transfusion Diagnostics Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Blood Grouping
7.3.2. Disease Screening
7.3.2.1. Molecular Disease Screening
7.3.2.2. Serological Disease Screening
7.4. Market Attractiveness Analysis, by Application
8. Global Blood Transfusion Diagnostics Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Diagnostics Laboratories
8.3.3. Blood Banks
8.3.4. Plasma Fractionation Companies
8.3.5. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Blood Transfusion Diagnostics Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Blood Transfusion Diagnostics Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2017–2031
10.3.1. Instruments
10.3.2. Kits & Reagents
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Blood Grouping
10.4.2. Disease Screening
10.4.2.1. Molecular Disease Screening
10.4.2.2. Serological Disease Screening
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Hospitals
10.5.2. Diagnostics Laboratories
10.5.3. Blood Banks
10.5.4. Plasma Fractionation Companies
10.5.5. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product Type
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe Blood Transfusion Diagnostics Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2017–2031
11.3.1. Instruments
11.3.2. Kits & Reagents
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Blood Grouping
11.4.2. Disease Screening
11.4.2.1. Molecular Disease Screening
11.4.2.2. Serological Disease Screening
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Diagnostics Laboratories
11.5.3. Blood Banks
11.5.4. Plasma Fractionation Companies
11.5.5. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Blood Transfusion Diagnostics Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2017–2031
12.3.1. Instruments
12.3.2. Kits & Reagents
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Blood Grouping
12.4.2. Disease Screening
12.4.2.1. Molecular Disease Screening
12.4.2.2. Serological Disease Screening
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Diagnostics Laboratories
12.5.3. Blood Banks
12.5.4. Plasma Fractionation Companies
12.5.5. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Blood Transfusion Diagnostics Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2017–2031
13.3.1. Instruments
13.3.2. Kits & Reagents
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Blood Grouping
13.4.2. Disease Screening
13.4.2.1. Molecular Disease Screening
13.4.2.2. Serological Disease Screening
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Diagnostics Laboratories
13.5.3. Blood Banks
13.5.4. Plasma Fractionation Companies
13.5.5. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Blood Transfusion Diagnostics Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product Type, 2017–2031
14.3.1. Instruments
14.3.2. Kits & Reagents
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Blood Grouping
14.4.2. Disease Screening
14.4.2.1. Molecular Disease Screening
14.4.2.2. Serological Disease Screening
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Diagnostics Laboratories
14.5.3. Blood Banks
14.5.4. Plasma Fractionation Companies
14.5.5. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Grifols, S.A.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Werfen
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Ortho Clinical Diagnostics
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Abbott
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Bio-Rad Laboratories, Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. F. Hoffmann-La Roche AG
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Alive Dx
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. BAG Health Care GmbH
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. DiaSorin S.p.A.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Hologic, Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 07: North America Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 11: Europe Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 12: Europe Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 15: Asia Pacific Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 16: Asia Pacific Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 19: Latin America Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 20: Latin America Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 23: Middle East & Africa Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by Application, 2017–2031
Table 24: Middle East & Africa Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Blood Transfusion Diagnostics Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
Figure 02: Global Blood Transfusion Diagnostics Market Revenue (US$ Mn), by Product Type, 2022
Figure 03: Global Blood Transfusion Diagnostics Market Value Share, by Product Type, 2022
Figure 04: Global Blood Transfusion Diagnostics Market Revenue (US$ Mn), by Application, 2022
Figure 05: Global Blood Transfusion Diagnostics Market Value Share, by Application, 2022
Figure 06: Global Blood Transfusion Diagnostics Market Revenue (US$ Mn), by End-user, 2022
Figure 07: Global Blood Transfusion Diagnostics Market Value Share, by End-user, 2022
Figure 08: Global Blood Transfusion Diagnostics Market Value Share, by Region, 2022
Figure 09: Global Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast, 2023–2031
Figure 10: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 11: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2023-2031
Figure 12: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 13: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2023-2031
Figure 14: Global Blood Transfusion Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 15: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2022-2031
Figure 16: Global Blood Transfusion Diagnostics Market Value Share Analysis, by Region, 2022 and 2031
Figure 17: Global Blood Transfusion Diagnostics Market Attractiveness Analysis, by Region, 2022-2031
Figure 18: North America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country, 2023–2031
Figure 20: North America Blood Transfusion Diagnostics Market Value Share Analysis, by Country, 2022 and 2031
Figure 21: North America Blood Transfusion Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 22: North America Blood Transfusion Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 23: North America Blood Transfusion Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 24: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 25: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2023–2031
Figure 26: North America Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 27: Europe Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 29: Europe Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 30: Europe Blood Transfusion Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 31: Europe Blood Transfusion Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 32: Europe Blood Transfusion Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 33: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 34: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2023–2031
Figure 35: Europe Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 36: Asia Pacific Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Asia Pacific Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 39: Asia Pacific Blood Transfusion Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 40: Asia Pacific Blood Transfusion Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 41: Asia Pacific Blood Transfusion Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 42: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 43: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2023–2031
Figure 44: Asia Pacific Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 45: Latin America Blood Transfusion Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 47: Latin America Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 48: Latin America Blood Transfusion Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 49: Latin America Blood Transfusion Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 50: Latin America Blood Transfusion Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 51: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 52: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2023–2031
Figure 53: Latin America Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031
Figure 54: Middle East & Africa Blood Transfusion Diagnostics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 56: Middle East & Africa Blood Transfusion Diagnostics Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 57: Middle East & Africa Blood Transfusion Diagnostics Market Value Share Analysis, by Product Type, 2022 and 2031
Figure 58: Middle East & Africa Blood Transfusion Diagnostics Market Value Share Analysis, by Application, 2022 and 2031
Figure 59: Middle East & Africa Blood Transfusion Diagnostics Market Value Share Analysis, by End-user, 2022 and 2031
Figure 60: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 61: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by Application, 2023–2031
Figure 62: Middle East & Africa Blood Transfusion Diagnostics Market Attractiveness Analysis, by End-user, 2023–2031